{"id":41223,"date":"2023-11-20T00:49:12","date_gmt":"2023-11-20T06:49:12","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/acrin-flt-breast-pub\/"},"modified":"2023-11-20T00:49:12","modified_gmt":"2023-11-20T06:49:12","slug":"acrin-flt-breast-pub","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/acrin-flt-breast-pub\/","title":{"rendered":"ACRIN-FLT-BREAST-PUB"},"template":"","class_list":["post-41223","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Publication Citation","tcia_citation_text":"<p>Kostakoglu, L., Duan, F., Idowu, M. O., Jolles, P. R., Bear, H. D., Muzi, M., Cormack, J., Muzi, J. P., Pryma, D. A., Specht, J. M., Hovanessian-Larsen, L., Miliziano, J., Mallett, S., Shields, A. F., &amp; Mankoff, D. A. (2015). <strong>A Phase II Study of 3\u2019-Deoxy-3\u2019-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688.<\/strong> Journal of Nuclear Medicine, 56(11), 1681\u20131689. <a href=\"https:\/\/doi.org\/10.2967\/jnumed.115.160663\">https:\/\/doi.org\/10.2967\/jnumed.115.160663<\/a><\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.2967\/jnumed.115.160663","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/41223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=41223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}